FDA scientists carry out laboratory, clinical and analytical research to address knowledge gaps in drug development, healthcare technologies and post-market drug monitoring. Spotlight on CDER Science features noteworthy scientific and research-oriented activities conducted within CDER.
Similar Posts
Drug Shortages
Drug Shortages HomepageConvenience Kit Recall: Medline Industries, LP, Removes Medline Neonatal and Pediatric Kits containing Smiths Medical ORAL/NASAL Endotracheal Tubes Due to Smaller Than Expected Tube Diameter That May Cause Underventilation
Medline Neonatal and Pediatric convenience kits that include Smiths Medical ORAL/NASAL Endotracheal Tubes are used for intubation.Sanofi S.p.A. – 05/22/2023
Sanofi S.p.A. – 05/22/2023. Country: Italy. Record Type: 483Made Fresh Salads, Inc. Recalls Assorted Flavors of Cream Cheese Because of Possible Health Risk
Made Fresh Salads, Inc. of Bay Shore, NY is recalling assorted flavors of cream cheese because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakenFDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Suspends Biologics License: FDA Safety Communication
On August 22, 2025,the US FDA’s Center for Biologics Evaluation and Research has suspended the biologics license for Valneva Austria GmbH’s Ixchiq (Chikungunya Vaccine, Live). This vaccine was initially approved by FDA under the accelerated approval pathway in November of 2023 for the prevention ofFagron Compounding Services. Wichita, KS. 483 issued 08/08/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 08/08/2025
Short Title (70 char) Fagron Compounding Services. Wichita, KS. 483 issued 08/08/2025
FEI Number 3012104093
Firm Name Fagron Compounding Services
Record Type 483
State KS